Dr. Jeri Ann Boose to Lead Lancaster Laboratories, Inc. Biologics Programs

Published: Jun 24, 2010

LANCASTER, Pa., June 24, 2010—Lancaster Laboratories, part of Thermo Fisher Scientific, today announced that leading biologics expert Jeri Ann Boose, Ph.D. has joined the company as director of Biopharmaceutical Services. In her new role, Dr. Boose will provide strategic, scientific and regulatory direction for the company’s rapidly expanding biopharmaceutical testing business, which includes extensive capabilities in the areas of biochemistry, cell and molecular biology and virology.

Dr. Boose has demonstrated expertise in the formulation of global regulatory product testing strategies and in the preparation of global regulatory filings at all stages of product development, as well as commercialization of new products for biopharmaceutical customers. Her specialties include knowledge of cGMP requirements, expectations and practices; assay and process validation; viral/TSE/microbial clearance validation; cell line characterization; raw materials testing; lot release testing; cleaning validation; and analytical and stability testing.

“The combination of Dr. Boose’s renowned expertise in biologics, coupled with our comprehensive biopharmaceutical capabilities, clearly positions Lancaster Laboratories as a leading provider of services to support the development and commercialization of biologics products,” says Dr. Timothy S. Oostdyk, executive vice president and COO of Lancaster Laboratories.

Dr. Boose brings 25 years of industry experience to the company’s growing Biopharmaceutical departments. Well-established as a leading authority in the areas of biosafety and, more specifically, virology, Dr. Boose has interfaced extensively with regulatory agencies throughout the world on both scientific and regulatory issues. Dr. Boose earned a Ph.D. from Georgetown University. She has published numerous papers in the field and has held positions in academics, government and industry.

About Lancaster Laboratories

Celebrating 50 years, Lancaster Laboratories is the global leader in pharmaceutical and biopharmaceutical laboratory services, providing innovative and timely scientific solutions that enable customers to better manage the drug development process. Visit lancasterlabspharm.com and discover why customers rank Lancaster Laboratories #1. Lancaster Laboratories is part of Thermo Fisher Scientific Inc.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.

Back to news